ReviewActa pharmaceutica Sinica. B2025
Advancements in CRISPR/Cas systems for disease treatment.
Yangsong Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewActa pharmaceutica Sinica. B2025
Yangsong Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.